These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8171869)

  • 21. Relations between diabetic retinopathy and cardiovascular neuropathy--a cross-sectional study in IDDM and NIDDM patients.
    Zander E; Heinke P; Herfurth S; Reindel J; Ostermann FE; Kerner W
    Exp Clin Endocrinol Diabetes; 1997; 105(6):319-26. PubMed ID: 9439926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.
    Bjornstad P; Maahs DM; Rewers M; Johnson RJ; Snell-Bergeon JK
    J Diabetes Complications; 2014; 28(6):762-6. PubMed ID: 25270733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications.
    Herman WH; Aubert RE; Engelgau MM; Thompson TJ; Ali MA; Sous ES; Hegazy M; Badran A; Kenny SJ; Gunter EW; Malarcher AM; Brechner RJ; Wetterhall SF; DeStefano F; Smith PJ; Habib M; abd el Shakour S; Ibrahim AS; el Behairy EM
    Diabet Med; 1998 Dec; 15(12):1045-51. PubMed ID: 9868980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
    Ebeling P; Koivisto VA
    Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The JEVIN trial: a population-based survey on the quality of diabetes care in Germany: 1994/1995 compared to 1989/1990.
    Schiel R; Müller UA; Sprott H; Schmelzer A; Mertes B; Hunger-Dathe W; Ross IS
    Diabetologia; 1997 Nov; 40(11):1350-7. PubMed ID: 9389429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of fibre intake to HbA1c and the prevalence of severe ketoacidosis and severe hypoglycaemia. EURODIAB IDDM Complications Study Group.
    Buyken AE; Toeller M; Heitkamp G; Vitelli F; Stehle P; Scherbaum WA; Fuller JH
    Diabetologia; 1998 Aug; 41(8):882-90. PubMed ID: 9726589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
    Levitt NS; Adams G; Salmon J; Marks IN; Musson G; Swanepoel C; Levy M; Byrne MJ
    Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early predictors of diabetic retinopathy in type 1 diabetes: The Retinopathy Champagne Ardenne Diabète (ReCAD) study.
    Diallo AM; Novella JL; Lukas C; Souchon PF; Dramé M; François M; Decoudier B; Barraud S; Salmon AS; Ancelle D; Arndt C; Delemer B
    J Diabetes Complications; 2018 Aug; 32(8):753-758. PubMed ID: 29980433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
    Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
    Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
    Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study.
    Kempler P; Tesfaye S; Chaturvedi N; Stevens LK; Webb DJ; Eaton S; Kerényi Z; Tamás G; Ward JD; Fuller JH;
    Diabet Med; 2002 Nov; 19(11):900-9. PubMed ID: 12421426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
    Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
    Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
    Johnson L; Rayner B
    Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
    Davies L; Fulcher GR; Atkins A; Frumar K; Monaghan J; Stokes G; Clifton-Bligh P; McElduff A; Robinson B; Stiel J; Twigg S; Wilmshurst E
    J Diabetes Complications; 1999; 13(1):45-51. PubMed ID: 10232709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and correlations of early microvascular complications in young type I diabetic patients: role of puberty.
    Bognetti E; Calori G; Meschi F; Macellaro P; Bonfanti R; Chiumello G
    J Pediatr Endocrinol Metab; 1997; 10(6):587-92. PubMed ID: 9467128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic diabetic complications in patients with MODY3 diabetes.
    Isomaa B; Henricsson M; Lehto M; Forsblom C; Karanko S; Sarelin L; Häggblom M; Groop L
    Diabetologia; 1998 Apr; 41(4):467-73. PubMed ID: 9562352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.